Survival outcomes also declined steadily with age, even among patients classified as having favorable genetic risk. For example, patients aged 18 to 24 with favorable-risk AML had a five-year overall ...
Survival rates for childhood leukemia are improving thanks to new treatments. Acute lymphoblastic leukemia has the highest survival among all pediatric cancers, 80-85 percent. Seattle Children’s ...
10hon MSN
Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
Compared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on ...
High rates of vulnerability on a geriatric assessment were identified in a cohort of fit patients aged 60 years or older with acute myeloid leukemia.
MedPage Today on MSN
Drug combo shows benefits in fit patients with acute myeloid leukemia
ORLANDO -- Azacitidine and venetoclax (Venclexta) significantly improved event-free survival (EFS) in newly diagnosed fit adults with acute myeloid leukemia (AML) compared with conventional induction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback